Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02367196
Title A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Scottsdale Healthcare Research Institute Scottsdale Arizona 85258 United States Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
University of California San Francisco San Francisco California 94143-1270 United States Details
Yale University School of Medicine New Haven Connecticut 06520-8073 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Hospital Universitari Germans Trias i Pujol Can Ruti Badalona (Barcelona) 08916 Spain Details
Hospital Val d'Hebron Barcelona 08035 Spain Details
Duran i Reynals Institut Catala d'Oncologia Barcelona 08907 Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Marques de Valdecilla Santander 39008 Spain Details
Hospital de la Fe Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field